Suppr超能文献

喹吖因对Kir4.1钾通道的抑制作用。

Inhibition of Kir4.1 potassium channels by quinacrine.

作者信息

Marmolejo-Murillo Leticia G, Aréchiga-Figueroa Iván A, Cui Meng, Moreno-Galindo Eloy G, Navarro-Polanco Ricardo A, Sánchez-Chapula José A, Ferrer Tania, Rodríguez-Menchaca Aldo A

机构信息

Centro Universitario de Investigaciones Biomédicas, Universidad de Colima, Colima, Col 28045, Mexico.

CONACYT, Facultad de Medicina, Universidad Autónoma de San Luis Potosí, San Luis Potosí, SLP 78210, Mexico.

出版信息

Brain Res. 2017 May 15;1663:87-94. doi: 10.1016/j.brainres.2017.03.009. Epub 2017 Mar 11.

Abstract

Inwardly rectifying potassium (Kir) channels are expressed in many cell types and contribute to a wide range of physiological processes. Particularly, Kir4.1 channels are involved in the astroglial spatial potassium buffering. In this work, we examined the effects of the cationic amphiphilic drug quinacrine on Kir4.1 channels heterologously expressed in HEK293 cells, employing the patch clamp technique. Quinacrine inhibited the currents of Kir4.1 channels in a concentration and voltage dependent manner. In inside-out patches, quinacrine inhibited Kir4.1 channels with an IC50 value of 1.8±0.3μM and with extremely slow blocking and unblocking kinetics. Molecular modeling combined with mutagenesis studies suggested that quinacrine blocks Kir4.1 by plugging the central cavity of the channels, stabilized by the residues E158 and T128. Overall, this study shows that quinacrine blocks Kir4.1 channels, which would be expected to impact the potassium transport in several tissues.

摘要

内向整流钾(Kir)通道在多种细胞类型中表达,并参与广泛的生理过程。特别是,Kir4.1通道参与星形胶质细胞的空间钾缓冲。在这项工作中,我们采用膜片钳技术,研究了阳离子两亲性药物奎纳克林对在HEK293细胞中异源表达的Kir4.1通道的影响。奎纳克林以浓度和电压依赖性方式抑制Kir4.1通道的电流。在向外膜片上,奎纳克林抑制Kir4.1通道,IC50值为1.8±0.3μM,阻断和解除阻断动力学极其缓慢。分子建模与诱变研究相结合表明,奎纳克林通过堵塞通道的中央腔来阻断Kir4.1通道,该中央腔由E158和T128残基稳定。总体而言,本研究表明奎纳克林阻断Kir4.1通道,预计这将影响多个组织中的钾转运。

相似文献

1
Inhibition of Kir4.1 potassium channels by quinacrine.
Brain Res. 2017 May 15;1663:87-94. doi: 10.1016/j.brainres.2017.03.009. Epub 2017 Mar 11.
2
Chloroquine blocks the Kir4.1 channels by an open-pore blocking mechanism.
Eur J Pharmacol. 2017 Apr 5;800:40-47. doi: 10.1016/j.ejphar.2017.02.024. Epub 2017 Feb 20.
3
Inhibition of astroglial inwardly rectifying Kir4.1 channels by a tricyclic antidepressant, nortriptyline.
J Pharmacol Exp Ther. 2007 Feb;320(2):573-80. doi: 10.1124/jpet.106.112094. Epub 2006 Oct 27.
4
The molecular basis of chloroethylclonidine block of inward rectifier (Kir2.1 and Kir4.1) K(+) channels.
Pharmacol Rep. 2016 Apr;68(2):383-9. doi: 10.1016/j.pharep.2015.10.005. Epub 2015 Nov 2.
5
Inhibition of astroglial Kir4.1 channels by selective serotonin reuptake inhibitors.
Brain Res. 2007 Oct 31;1178:44-51. doi: 10.1016/j.brainres.2007.08.018. Epub 2007 Aug 16.
6
High-potency block of Kir4.1 channels by pentamidine: Molecular basis.
Eur J Pharmacol. 2017 Nov 15;815:56-63. doi: 10.1016/j.ejphar.2017.10.009. Epub 2017 Oct 6.
9
Mutational and in silico analyses for antidepressant block of astroglial inward-rectifier Kir4.1 channel.
Mol Pharmacol. 2009 Jun;75(6):1287-95. doi: 10.1124/mol.108.052936. Epub 2009 Mar 5.
10
Hyperglycemia reduces functional expression of astrocytic Kir4.1 channels and glial glutamate uptake.
Neuroscience. 2015 Dec 3;310:216-23. doi: 10.1016/j.neuroscience.2015.09.044. Epub 2015 Sep 25.

引用本文的文献

2
VU6036720: The First Potent and Selective In Vitro Inhibitor of Heteromeric Kir4.1/5.1 Inward Rectifier Potassium Channels.
Mol Pharmacol. 2022 May;101(5):357-370. doi: 10.1124/molpharm.121.000464. Epub 2022 Mar 3.
3
Emerging Roles of Astrocyte Kir4.1 Channels in the Pathogenesis and Treatment of Brain Diseases.
Int J Mol Sci. 2021 Sep 23;22(19):10236. doi: 10.3390/ijms221910236.
4
Kir Channel Molecular Physiology, Pharmacology, and Therapeutic Implications.
Handb Exp Pharmacol. 2021;267:277-356. doi: 10.1007/164_2021_501.
5
Role of Astrocytic Inwardly Rectifying Potassium (Kir) 4.1 Channels in Epileptogenesis.
Front Neurol. 2020 Dec 23;11:626658. doi: 10.3389/fneur.2020.626658. eCollection 2020.
6
In vitro and in silico characterization of the inhibition of Kir4.1 channels by aminoglycoside antibiotics.
Br J Pharmacol. 2020 Oct;177(19):4548-4560. doi: 10.1111/bph.15214. Epub 2020 Aug 17.
7
Inwardly Rectifying Potassium Channel Kir4.1 as a Novel Modulator of BDNF Expression in Astrocytes.
Int J Mol Sci. 2018 Oct 24;19(11):3313. doi: 10.3390/ijms19113313.

本文引用的文献

2
Role and mechanisms of regulation of the basolateral K 4.1/K 5.1K channels in the distal tubules.
Acta Physiol (Oxf). 2017 Jan;219(1):260-273. doi: 10.1111/apha.12703. Epub 2016 May 20.
3
The role of glial-specific Kir4.1 in normal and pathological states of the CNS.
Acta Neuropathol. 2016 Jul;132(1):1-21. doi: 10.1007/s00401-016-1553-1. Epub 2016 Mar 9.
4
The molecular basis of chloroethylclonidine block of inward rectifier (Kir2.1 and Kir4.1) K(+) channels.
Pharmacol Rep. 2016 Apr;68(2):383-9. doi: 10.1016/j.pharep.2015.10.005. Epub 2015 Nov 2.
7
Contribution of KCNJ10 gene polymorphisms in childhood epilepsy.
J Child Neurol. 2015 Mar;30(3):296-300. doi: 10.1177/0883073814539560. Epub 2014 Jul 9.
8
Cardiac and renal inward rectifier potassium channel pharmacology: emerging tools for integrative physiology and therapeutics.
Curr Opin Pharmacol. 2014 Apr;15:7-15. doi: 10.1016/j.coph.2013.11.002. Epub 2013 Nov 26.
10
Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice.
Nat Neurosci. 2014 May;17(5):694-703. doi: 10.1038/nn.3691. Epub 2014 Mar 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验